GEMINI-1 and -2: DTG + 3TC Noninferior to DTG + FTC/TDF at Wk 96 in ART-Naive Adults

July 21-24, 2019; Mexico City, Mexico
In prespecified secondary analyses, HIV-1 RNA < 50 copies/mL achieved by 86.0% of patients receiving dual therapy vs 89.5% receiving triple-drug ART.
Format: Microsoft PowerPoint (.ppt)
File Size: 279 KB
Released: July 24, 2019

Acknowledgements

Provided by USF

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Produced in collaboration with
IAS 2019 Media Partner Logo
Educational grant provided by:
Gilead Sciences
ViiV Healthcare

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings